Citations

Clear

4847 citation(s) found for "Yu, Eric".

Spontaneous coronary artery dissection: challenges of coronary computed tomography angiography
Eleid, Mackram F. , Young, Phillip M. , Williamson, Eric E. , Gulati, Rajiv , Tweet, Marysia S. , Hayes, Sharonne N.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | January 31, 2017 | Volume: 7 | Issue: 7 | Pages: 609-613

10.1177/2048872616687098 | PMID 28139136 Get It

Background: There is limited understanding of the role of cardiac computed tomography angiography (CCTA) for assessment of patients with spontaneous coronary artery dissection (SCAD). Methods: In this report we describe the diagnostic utility of CCTA in three young women presenting with signs and symptoms of myocardial ischemia who were eventually diagnosed with SCAD. Results: None of the women had traditional atherosclerotic risk factors. SCAD was not initially identified on CCTA in any of the three women, but was visualized during retrospective analysis in two patients after invasive coronary angiography. In two patients follow-up CCTA imaging was used successfully for subsequent management. Conclusions: In patients presenting with signs or symptoms of acute coronary syndrome, SCAD may be missed or not detectable on CCTA. A negative CCTA should not exclude a diagnosis of SCAD, and invasive coronary angiography should be considered for further evaluation.
Workshop on imaging science development for cancer prevention and preemption
Kelloff, Gary J. , Sullivan, Daniel C. , Baker, Houston, Clarke, Lawrence, Nordstrom, Robert J. , Tatum, James L. , Dorfman, Gary S., Berg, Christine D. , Birrer, Michael J. , Tempero, Margaret A. , Higley, Howard R., Petty, Brenda Gumbs, Sigman, Caroline C. , Ginsberg, Gregory G. , Dannenberg, Andrew J. , Hawk, Ernest T. , Messing, Edward M. , Grossman, H. Barton, Griebel, Donna, Henson, Donald E., Fabian, Carol J. , Zujewski, Jo Anne , Hayes, Wendy, Klein, Eric A. , Ocak, İclal , Tempany, Clare M. , Shtern, Faina, Parnes, Howard L. , Gómez, Jorge , Srivastava, Sudhir , Lam, Stephen , Seibel, Eric J. , Massion, Pierre P. , McLennan, Geoffrey, Burt, Randall W., Hoffman, John M. , El‐Deiry, Wafik S. , Papadimitrakopoulou, Vali, Veltri, Robert W., Solomon, Diane, Viner, Jaye L., Stratton, Steven P. , Rajadhyaksha, Milind , Dhawan, Atam P. , Jacobs, Paula , Pomper, Martin G. , Maley, Carlo C. , Sharma, Prateek , Wax, Adam , Harisinghani, Mukesh G. , Bigio, Irving J. , Ferrara, Katherine W. , Fantini, Sergio , Schnall, Mitchell D. , Zujewski, Jo Anne , Marzo, Angelo M. De , Ketterling, Jeffrey A. , Szabó, Éva , Cleary, Kevin , Suh, Robert D. , Pfeiffer, Ruth M. , Roy, Hemant K. , Wang, Thomas J. , Limburg, Paul J. , Hittelman, Walter N. , MacAulay, Calum E. , Jerónimo, José , Richards‐Kortum, Rebecca , Johnson, Karen A. , Klein, Eric A

Mayo Clinic

Cancer Biomarkers | January 31, 2017 | Volume: 3 | Issue: 1 | Pages: 1-33

10.3233/cbm-2007-3101 | PMID 17655039 Get It

The Influence of 17 Hours of Normobaric Hypoxia on Parallel Adjustments in Exhaled Nitric Oxide and Airway Function in Lowland Healthy Adults
Iterson, Erik H. Van , Snyder, Eric M., Johnson, Bruce D. , Van Iterson, Erik H, Van Iterson, Erik H

Mayo Clinic

High Altitude Medicine & Biology | January 30, 2017 | Volume: 18 | Issue: 1 | Pages: 1-10

10.1089/ham.2016.0086 | PMID 28135110 Get It

A novel de novo frameshift deletion in EHMT1 in a patient with Kleefstra Syndrome results in decreased H3K9 dimethylation
Blackburn, Patrick R. , Williams, Monique , Cousin, Margot A. , Boczek, Nicole J. , Beek, Geoffrey, Lomberk, Gwen , Babovic‐Vuksanovic, Dusica , Klee, Eric W. , Beek, Geoffrey J, Lomberk, Gwen A, Urrutia, Raul A, Babovic-Vuksanovic, Dusica, Urrutia, Raúl , Lomberk, Gwen L

Mayo Clinic

Molecular Genetics & Genomic Medicine | January 26, 2017 | Volume: 5 | Issue: 2 | Pages: 141-146

10.1002/mgg3.268 | PMID 28361100 Get It

AbstractBackgroundKleefstra Syndrome (KS) (MIM# 610253) is an autosomal dominant disorder caused by haploinsufficiency of euchromatic histone methyltransferase‐1 (EHMT1, GLP). EHMT1 (MIM# 607001) encodes a histone methyltransferase that heterodimerizes with EHMT2 (also known as G9a, MIM# 604599), which together are responsible for mono‐ and dimethylation of H3 lysine 9 (H3K9me1 and ‐me2), resulting in transcriptional repression of target genes.MethodsThis report describes an 18‐year‐old woman with intellectual disability, severely limited speech, hypotonia, microcephaly, and facial dysmorphisms, who was found to have a novel de novo single‐base frameshift deletion in EHMT1.ResultsFunctional studies using patient fibroblasts showed decreased H3K9me2 compared to wild‐type control cells, thus providing a rapid confirmatory test that complements molecular studies.ConclusionWhole exome sequencing revealed a novel frameshift deletion in EHMT1 after a lengthy diagnostic odyssey in this patient. Functional testing using this patient's fibroblasts provides proof‐of‐concept for the analysis of variants of uncertain significance that are predicted to impact EHMT1 enzymatic activity.
Trinucleotide Repeat Expansion in the Transcription Factor 4 ( TCF4 ) Gene Leads to Widespread mRNA Splicing Changes in Fuchs' Endothelial Corneal Dystrophy
Wieben, Eric D. , Aleff, Ross A., Tang, Xiaojia , Butz, Malinda L., Kalari, Krishna R. , Highsmith, Edward W., Jen, Jin , Vasmatzis, George , Patel, Sanjay V. , Maguire, Leo J., Baratz, Keith H. , Fautsch, Michael P. , Kalari, Krishna R , Patel, Sanjay V , Tang, Xiaojia

Mayo Clinic

Investigative Opthalmology & Visual Science | January 24, 2017 | Volume: 58 | Issue: 1 | Pages: 343

10.1167/iovs.16-20900 | PMID 28118661 Get It

Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine
Freimuth, Robert R. , Formea, CM, Jm, Hoffman, Matey, Eric T. , Peterson, JF, Boyce, RD, Peterson, Josh F. , Peterson, JF, Freimuth, Robert R , Peterson, Josh F

Mayo Clinic

CPT: Pharmacometrics & Systems Pharmacology | January 20, 2017 | Volume: 6 | Issue: 3 | Pages: 153-155

10.1002/psp4.12173 | PMID 28109071 Get It

Evaluation of a 24‐gene signature for prognosis of metastatic events and prostate cancer‐specific mortality
Pellegrini, Kathryn L. , Sanda, Martin G. , Patil, Dattatraya , Long, Qi , Santiago‐Jiménez, María , Takhar, Mandeep, Erho, Nicholas , Yousefi, Kasra, Klein, Eric A. , Jenkins, Robert B. , Karnes, R. Jeffrey , Moreno, Carlos S. , Davicioni, Elai , Klein, Eric A , Patil, Dattatraya H , Long, Qi

Mayo Clinic

BJU International | January 20, 2017 | Volume: 119 | Issue: 6 | Pages: 961-967

10.1111/bju.13779 | PMID 28107602 Get It

Objectives To determine the prognostic potential of a 24‐gene signature, Sig24, for identifying patients with prostate cancer who are at risk of developing metastases or of prostate cancer‐specific mortality (PCSM) after radical prostatectomy (RP). Patients and Methods Sig24 scores were calculated from previously collected gene expression microarray data from the Cleveland Clinic and Mayo Clinic (I and II). The performance of Sig24 was determined using time‐dependent c‐index analysis, Cox proportional hazards regression and Kaplan–Meier survival analysis. Results Higher Sig24 scores were significantly associated with higher pathological Gleason scores in all three cohorts. Analysis of the Mayo Clinic II cohort, which included time‐to‐event information, indicated that patients with high Sig24 scores also had a higher risk of developing metastasis (hazard ratio [HR] 3.78, 95% confidence interval [CI]: 1.96–7.29; P < 0.001) or of PCSM (HR 6.54, 95% CI: 2.16–19.83; P < 0.001). Conclusions The findings of the present study show the applicability of Sig24 for the prognosis of metastasis or PCSM after RP. Future studies investigating the combination of Sig24 with available prognostic tests may provide new approaches to improve risk stratification for patients with prostate cancer.
De novo 2p16.1 microdeletion with metastatic esophageal adenocarcinoma
Codipilly, Don C. , Gavrilova, Ralitza H. , Tangalos, Eric G., Codipilly, Don Chamil

Mayo Clinic

BMJ Case Reports | January 20, 2017 | Volume: 2017 | Issue: No issue available | Pages: bcr2016218016

10.1136/bcr-2016-218016 | PMID 28108439 Get It

Microdeletions involving chromosome 2p15-16.1 are a rare genetic abnormality and have been reported in 18 separate patients, mainly children, since 2007. This microdeletion syndrome is characterised by a heterogeneous expression of intellectual impairment, dysmorphic facies, musculoskeletal abnormalities and potential neurodevelopmental anomalies. We report the first case of natural progression in an adult patient who died at a young age of metastatic esophageal adenocarcinoma. Important learning points include the variable phenotypic expression of this microdeletion syndrome and the fact that clinicians must be thorough in investigating objective discrepancies in patients who cannot endorse classical symptoms.
Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States
Mathur, Amit K. , Steidley, D. Eric , Heilman, Raymond L. , Khurmi, Narjeet , Wasif, Nabil , Etzioni, David A. , Moss, Adyr A. , Heilman, Raymond, Etzioni, David, Chang, Yu‐Hui

Mayo Clinic

Transplantation Direct | January 17, 2017 | Volume: 3 | Issue: 2 | Pages: e126

10.1097/txd.0000000000000640 | PMID 28361110 Get It

Background Cardiovascular disease (CVD) is an important driver of mortality after kidney transplantation. Its broader impact on posttransplant health care utilization in US hospitals is unknown. Methods We used administrative claims data from the Nationwide Inpatient Sample and the American Hospital Association Annual Survey to identify hospitalizations for kidney transplant patients with a cardiovascular diagnosis from 2005 to 2011. CVD hospitalizations were stratified by transplant hospital status to characterize patterns in inpatient health care utilization and outcomes. Based on these analyses, the domestic burden of treatment for posttransplant CVD (myocardial infarction, stroke, congestive heart failure, dysrhythmia, cardiac arrest, malignant hypertension) was estimated. Results The total domestic burden of post-kidney transplant hospitalization between 2005 and 2011 is estimated at 389 138 of which 26.5% of episodes were related to CVD (n = 103 118). CVD was responsible for a growing proportion of post-transplant hospitalizations over time (24.4%-30.4%, P < 0.001). Compared with nontransplant hospitals, transplant hospitals had similar length of stay (median length of stay, 3.7 days), higher median costs per hospitalization (US $10 364 vs US $8606, overall US $9324), and lower adjusted mortality (3.2% vs 3.9%, overall 3.6%; P = 0.003). Conclusions Inpatient CVD care is increasing over time for kidney transplant patients, accounting for 30% of all post-transplant hospitalizations. Variation exists in the inpatient care, outcomes, and costs between by hospital type. Further studies are needed to better understand the mechanisms behind these phenomena.